Tuesday, 20 March 2012

The European Association Of Urology-Prostate Cancer

The challenge of prostate cancer drug approval versus reimbursement

Here at the European Association of Urology (EAU) congress in Paris, there are some interesting debates amongst delegates attending the meeting regarding new therapies either recently – or about to be approved – for castrate-resistant prostate cancer (CRPC). For example: … Continue reading ? read more..

No comments:

Post a Comment